Events | 2016.08.12
Acacia Pharma Announces Positive Results From a Pivotal Phase 3 Trial of BAREMSIS™ for the Treatment of Post-Operative Nausea & Vomiting
CAMBRIDGE, England, August 12, 2016 /PRNewswire/ -- BAREMSIS Now Shown to Treat PONV, as Well as Prevent it Acacia Pharma Group plc ("Acacia Pharma"), the supportive care company developing products for US and international markets, announces positive results from a pivotal Phase...
For more information, please visit
http://www.prnewswire.com/news-releases/[...]ausea--vomiting-589958131.html
